Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase.Xiao L, Salem JE, Clauss S, Hanley A, Bapat A, Hulsmans M, Iwamoto Y, Wojtkiewicz G, Cetinbas M, Schloss MJ, Tedeschi J, Lebrun-Vignes B, Lundby A, Sadreyev RI, Moslehi J, Nahrendorf M, Ellinor PT, Milan DJ
(2020)
Circulation 142: 2443-2455
MeSH Terms: Action Potentials, Adenine, Agammaglobulinaemia Tyrosine Kinase, Animals, Antineoplastic Agents, Atrial Fibrillation, Atrial Function, Left, CSK Tyrosine-Protein Kinase, Databases, Genetic, Heart Atria, Heart Rate, Humans, Mice, 129 Strain, Mice, Inbred C57BL, Mice, Inbred CBA, Mice, Knockout, Piperidines, Protein Kinase Inhibitors, Risk Assessment, Risk FactorsAdded January 23, 2021